Webinar: Disruptions to childhood immunization during the COVID-19 pandemic: Health impact modeling and economic perspectives

September 22, 2021

Part of the fall 2021 inaugural webinar series of the Immunization Economics SIG that focuses on current research relevant to the immunization economics community of practice.

In the second session Mark Jit, Han Fu, and Kaja Abbas will present “Disruptions to childhood immunization during the COVID-19 pandemic: health impact modeling and economic perspectives.” National immunization programs globally have been disrupted due to the severe health system constraints caused by the ongoing COVID-19 pandemic and the public health and social measures to mitigate the outbreak. The speakers will present health impact modeling studies and economic perspectives on disruptions to routine childhood immunization and vaccination campaigns. Mark Jit, Han Fu, and Kaja Abbas are part of the Modelling and Economic Evaluation of Vaccines group at LSHTM (https://meev.lshtm.ac.uk), and conduct applied epidemiological and economic research to inform public health decisions about vaccination.

 

Register here.

 

You May Also Like

VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

The Vaccine Procurement Practitioners Network (VPPN) will conclude their series on market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French. This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement … Read More

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More